AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The analysis evaluated the efficacy of upadacitinib (15 mg or ...
The U.S. Food and Drug Administration (FDA) today announced it approved the nasal influenza vaccine FluMist® for self- or caregiver-administration by adults. This innovative flu shot is sprayed ...